Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak
Authors:
Open Access
- 25 January 2021
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 21 (1) , 1-10
Abstract
Background: To examine the clinical characteristics and identify independent risk factors for in-hospital mortality of 2019 novel coronavirus (COVID-19) pneumonia. Methods: A total of 156 patients diagnosed with COVID-19 pneumonia at the Central Hospital of Wuhan from January 29, 2020, to March 20, 2020, and 20 healthy individuals were enrolled in this single-centered retrospective study. The epidemiological parameters, clinical presentations, underlying diseases, laboratory test results, and disease outcomes were collected and analyzed. Results: The median age of all enrolled patients was 66 years. At least one underlying disease was identified in 101 COVID-19 patients, with hypertension being the most common one, followed by cardiovascular disease and diabetes. The most common symptoms identified upon admission were fever, cough, dyspnea, and fatigue. Compared to survival cases, patients who died during hospitalization had higher plasma levels of D-dimer, creatinine, creatine kinase, lactate dehydrogenase, lactate, and lower percentage of lymphocytes (LYM [%]), platelet count and albumin levels. Most enrolled patients received antibiotics and anti-viral treatment. In addition, 60 patients received corticosteroids, and 51 received intravenous immunoglobulin infusion. Forty-four patients received noninvasive ventilation and 19 received invasive ventilation. Respiratory failure was the most frequently observed complication (106 [67.9%]), followed by sepsis (103 [66.0%]), acute respiratory distress syndrome (ARDS) (67 [42.9%]), and septic shock (50 [32.1%]). Multivariable regression suggested that advanced age (OR [odds ratio] = 1.098, 95% CI [confidence interval]: 1.006–1.199, P = 0.037), shorter duration from onset to admission (OR = 0.853, 95% CI: 0.750–0.969, P = 0.015) and elevated lactate level upon admission (OR = 2.689, 95% CI: 1.044–6.926, P = 0.040) were independent risk factors for in-hospital mortality for COVID-19 infection. Meanwhile, increased LYM (%) at admission (OR = 0.787, 95% CI: 0.686–0.903, P = 0.001) indicated a better prognosis. Conclusions: In this study, we discovered that age, duration from onset to admission, LYM (%), and lactate level upon admission were independent factors that affecting the in-hospital mortality rate.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Developing a New Definition and Assessing New Clinical Criteria for Septic ShockJAMA, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Lactic Acidosis in Sepsis: It’s Not All AnaerobicChest, 2016
- d-dimer is a significant prognostic factor in patients with suspected infection and sepsisThe American Journal of Emergency Medicine, 2012
- Acute Respiratory Distress SyndromeJAMA, 2012
- Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human PrimatesPLOS Pathogens, 2010
- Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock*Critical Care Medicine, 2009
- The Immunopathogenesis of Sepsis in Elderly PatientsClinical Infectious Diseases, 2005
- Characterization of Cytokine/Chemokine Profiles of Severe Acute Respiratory SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Short term outcome and risk factors for mortality in adults with critical severe acute respiratory syndrome (SARS)Current Medical Science, 2004